Keshuai Dong
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
SHC4 suppresses ferroptosis and promotes sorafenib resistance in hepatocellular carcinoma by disrupting the interaction between NCOA4 and FTH1.
Journal: Cellular signalling
Published: February 05, 2026
SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma.
Journal: International immunopharmacology
Published: November 09, 2025
RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway.
Journal: International journal of oncology
Published: August 27, 2025
Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: October 22, 2023
Construction of a Nomogram to Predict Overall Survival in Patients with Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study.
Journal: Cancers
Published: October 18, 2023
Leveraging an immune cell signature to improve the survival and immunotherapy response of lung adenocarcinoma.
Journal: Journal of Cancer
Published: September 25, 2023
Characteristics of lactate metabolism phenotype in hepatocellular carcinoma.
Journal: Scientific reports
Published: July 13, 2023
Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis.
Journal: Journal of clinical medicine
Published: January 27, 2023
Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies.
Journal: International immunopharmacology
Published: December 02, 2022
GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling.
GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling.
Journal: Cancer science
Published: November 01, 2022
Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy.
Journal: Frontiers in pharmacology
Published: August 13, 2022
Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.
Journal: Frontiers in microbiology
Published: May 18, 2022
Last Updated: 09/26/2026